Maternal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGF BP-3 and the hypertensive disorders of pregnancy

References

• Zapf J, Waldvogel M, Froesch ER. Binding of non-suppressible insulin like activity to human serum. Evidence for a carrier protein. Arch Biochem Biophysics 1975;168:638–645.
   PubMed Web of Science ®Google Scholar
• Hintz RL, Liu F. Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab 1977;45:988–995.
   PubMed Web of Science ®Google Scholar
• Davis SR, Hodgkinson SC, Moore LG. Improved estimates of clearance of 131 I-labelled insulin-like growth factor 1 carrier protein complexes from blood plasma of sheep. J Endocrinol 1989;123:469–475.
   PubMed Web of Science ®Google Scholar
• Francis GL, McMurty JP, Johnson RJ. Plasma clearance of chicken and human insulin-like growth factor-1 and their association with circulating binding proteins in chickens. J Endocrinol 1990;124:361–370.
   PubMed Web of Science ®Google Scholar
• Wang HS, Lee CL, Chard T. Levels of insulin-like growth factor-1 and insulin-like growth factor-binding protein-1 in pregnancy with preterm delivery. Br J Obstet Gynaecol 1993;100:472–475.
   PubMedGoogle Scholar
• Hills FA, English J, Chard T. Circulating levels of IGF-1 and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 1996;148:303–309.
   PubMed Web of Science ®Google Scholar
• Holmes R, Montemagno R, Jones J. Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth. Early Hum Dev 1997;49:7–17.
   PubMed Web of Science ®Google Scholar
• Wang HS, Lim J, English J. The concentration of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-1 (IGFBP-1) in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol 1991;129:459–464.
   PubMed Web of Science ®Google Scholar
• Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892–898.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447–1451.
   PubMed Web of Science ®Google Scholar
• Robertson Rather natural history of oedema during pregnancy. J Obstet Gynaecol Br Commonwealth 1971;78:520.
   PubMedGoogle Scholar
• Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician 2008;78:93–100.
   PubMed Web of Science ®Google Scholar
• Garovic VD. Hypertension in pregnancy: diagnosis and treatment. Mayo Clin Proc 2000;75:1071–1076. Review.
   PubMed Web of Science ®Google Scholar
• Tjoa ML, Oudejans CB, van Vugt JM, Blankenstein MA, van Wijk IJ. Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction. Hypertens Pregn 2004;23:171–189. Review.
   PubMed Web of Science ®Google Scholar
• Bersinger NA, Smárason AK, Muttukrishna S, Groome NP, Redman CW. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Pregn 2003;22:45–55.
   PubMed Web of Science ®Google Scholar
• Singh HJ, Abu Bakar A, Che Romli A, Nila A. Raised leptin concentrations in feto-placental tissues from women with preeclampsia. Hypertens Pregn 2005;24:191–199.
   PubMed Web of Science ®Google Scholar
• Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003;88:2393–2398. Review.
   PubMed Web of Science ®Google Scholar
• Gluckman PD, Johnson-Barrett JJ, Butler JH. Studies of the insulin-like growth factor I and II by specific radioligands in umbilical cord blood. Clin Endocrinol 1983;19:405–413.
   PubMed Web of Science ®Google Scholar
• Langford KS, Nicolaides KH, Jones J, Abbas A, McGregor AM, Miell JP. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal and multiple human pregnancy. J Clin Endocrinol Metab 1995;80:21–27.
   PubMed Web of Science ®Google Scholar
• Pedersen JF, Juul A, Molsted-Pedersen L, Skakkebaek NE. Serum levels of insulin-like growth factor-1 in first trimester of diabetic pregnancy: relation to early growth delay. Br J Obstet Gynaecol 1995;102:927–928.
   PubMedGoogle Scholar
• Bernstein I, Goran MI, Copeland KC. Maternal insulin sensitivity and cord blood peptides: relationships to neonatal size at birth. Obstet Gynecol 1997;90:780–783.
   PubMed Web of Science ®Google Scholar
• Wizniter A, Reece EA, Homko C, Furman B, Mazor M, Levy J. Insulin-like growth factors, their binding proteins, and fetal macrosomia in offspring of nondiabetic pregnant women. Am J Perinatol 1998;15:23–28.
   PubMed Web of Science ®Google Scholar
• Cooley SM, Donnelly JC, Geary MP, Rodeck CH, Hindmarsh PC. Maternal and fetal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGF BP-3, and their relationship to fetal acidosis at delivery. J Perinat Med 2004;32:418–421.
   PubMed Web of Science ®Google Scholar
• Barker DJP. Fetal and infant origins of adult diseaseLondon: BMJ Eds; 1992.
   Google Scholar
• Burkhardt T, Matter CM, Lohmann C, Cai H, Lüscher TF, Zisch AH, Beinder E. Decreased umbilical artery compliance and IGF-I plasma levels in infants with intrauterine growth restriction – implications for fetal programming of hypertension. Placenta 2009;30:136–141.
   PubMed Web of Science ®Google Scholar
• Wang HS, Lee JD, Cheng BJ, Soong YK. Insulin-like growth factor binding protein-1 (IGFBP-1) and insulin-like growth factor-binding protein-3 (IGFBP-3) in pre-eclampsia. Br J Obstet Gynaecol 1996;103:654–659.
   PubMedGoogle Scholar